Molecular and Hormonal Responses to Diet-Induced Insulin Resistance

March 15, 2019 updated by: Carl Hulston, Loughborough University
This study determined the effect of 7 days of high-fat overfeeding on whole-body glycaemic control, glucose kinetics, skeletal muscle insulin signalling, and markers of skeletal muscle microvascular function in 15 healthy young individuals.

Study Overview

Status

Completed

Conditions

Detailed Description

Fifteen healthy, young individuals underwent metabolic testing before and after 7 days of high-fat overfeeding. We determined whole-body glycaemic control, glucose kinetics, skeletal muscle insulin signalling, and markers of skeletal muscle microvascular function. Stable isotope tracers were used to assess the rate of appearance of glucose from the gut, liver glucose output and whole-body glucose disposal. Insulin signalling was determined by Western blotting of skeletal muscle tissue. Microvascular function was assessed through the use of quantitative immunofluorescence microscopy. These measurements were performed both postabsorptively and following the ingestion of 50 grams of glucose + 15 grams of protein.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and 40 years
  • Physically active
  • Non-smoker
  • Not taking any medication known to interfere with the study
  • No history of cardiovascular disease or diabetes
  • Weight stable for the last 6 months

Exclusion Criteria:

  • Outside of age range
  • Sedentary
  • Smoker
  • Taking medication known to interfere with the study
  • History of cardiovascular disease or diabetes
  • Unstable weight within last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-fat diet
Participants underwent a 7 day high-fat, high-energy diet intervention with metabolic measurements before and after
Participants consumed a diet that was high in fat and high in energy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in glucose concentration
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Venous blood samples were obtained the day before and the day after the 7 day high-fat diet. Glucose was reported as mmol/L.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Change in insulin concentration
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Venous blood samples were obtained the day before and the day after the 7 day high-fat diet. Insulin was reported as pmol/L.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Change in glucose kinetics (i.e., rate of appearance and disappearance) assessed using isotope tracers
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Glucose kinetics were assessed the day before and the day after the 7 day high-fat diet. Data expressed as umol/kg/min.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Change in skeletal muscle insulin signalling
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
AKT and AS160 phosphorylation was determined by Western blotting of skeletal muscle. Data are expressed as arbitrary units.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Change in markers of microvascular function
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
endothelial nitric oxide synthase was determined in terminal arterioles by quantitative immunofluorescence microscopy that was performed on sections of skeletal muscle tissue. Data presented as arbitrary units.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change intramuscular triglyceride content
Time Frame: Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Intramuscular triglyceride content was determined by quantitative immunofluorescence microscopy that was performed on sections of skeletal muscle tissue. Data presented as arbitrary units.
Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2015

Primary Completion (Actual)

May 22, 2018

Study Completion (Actual)

May 22, 2018

Study Registration Dates

First Submitted

March 12, 2019

First Submitted That Met QC Criteria

March 15, 2019

First Posted (Actual)

March 18, 2019

Study Record Updates

Last Update Posted (Actual)

March 18, 2019

Last Update Submitted That Met QC Criteria

March 15, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • R13-P171

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on High-fat, high-energy diet

Subscribe